About the Urethral Cancer Session
Urethral cancer is a rare form of cancer that develops in the urethra, the tube that carries urine from the bladder out of the body. Research on urethral cancer is challenging due to its rarity and diverse subtypes, including squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma. Current studies focus on understanding the molecular mechanisms underlying urethral cancer development, exploring targeted therapies, and improving early detection methods. Advances in genomic profiling have provided insights into the genetic alterations driving urethral cancer, paving the way for personalized treatment approaches. Additionally, clinical trials are evaluating novel immunotherapy agents and combination therapies to enhance treatment outcomes. Despite the challenges, ongoing research efforts offer hope for improved management and outcomes for individuals affected by urethral cancer.
Topics Covered in Urethral Cancer
Urothelial Carcinoma
Squamous Cell Subtype
Adenocarcinoma
Proximal & Distal Tumors
Cystourethroscopy
Multimodal Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Urethral Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Urethral Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Urethral Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Urethral Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Urethral Cancer Conference 2027 — FAQs
What is the Urethral Cancer track at CIOC 2027?
The Urethral Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Urethral Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Urethral Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Urethral Cancer are all welcome — whether presenting or attending.
Can I present my research in the Urethral Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Urethral Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Urethral Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.